Hear AtLast Holdings, Inc. (HRAL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 3.04 Million USD | 6.09% |
| 2021 | 2.86 Million USD | 1.23% |
| 2020 | 2.83 Million USD | -8.65% |
| 2019 | 3.09 Million USD | 115.76% |
| 2018 | 1.43 Million USD | 0.21% |
| 2017 | 1.43 Million USD | 7.5% |
| 2016 | 1.33 Million USD | 0.0% |
| 2015 | 1.33 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 3.09 Million USD | 1.69% |
| 2023 Q2 | 3.15 Million USD | 2.06% |
| 2023 Q3 | 3.2 Million USD | 1.71% |
| 2022 FY | 3.04 Million USD | 6.09% |
| 2022 Q3 | 3.01 Million USD | 1.73% |
| 2022 Q2 | 2.96 Million USD | 3.5% |
| 2022 Q4 | 3.04 Million USD | 0.73% |
| 2022 Q1 | 2.86 Million USD | 0.03% |
| 2021 Q1 | 2.79 Million USD | -1.1% |
| 2021 FY | 2.86 Million USD | 1.23% |
| 2021 Q2 | 2.85 Million USD | 1.81% |
| 2021 Q4 | 2.86 Million USD | 0.82% |
| 2021 Q3 | 2.84 Million USD | -0.27% |
| 2020 Q4 | 2.83 Million USD | -1.09% |
| 2020 Q3 | 2.86 Million USD | -0.26% |
| 2020 FY | 2.83 Million USD | -8.65% |
| 2020 Q1 | 3.04 Million USD | -1.65% |
| 2020 Q2 | 2.86 Million USD | -5.85% |
| 2019 Q1 | 1.74 Million USD | 6.14% |
| 2019 Q4 | 3.09 Million USD | 50.88% |
| 2019 Q3 | 2.05 Million USD | 4.57% |
| 2019 Q2 | 1.96 Million USD | 12.64% |
| 2019 FY | 3.09 Million USD | 115.76% |
| 2018 Q2 | 1.43 Million USD | 0.0% |
| 2018 FY | 1.43 Million USD | 0.21% |
| 2018 Q4 | 1.64 Million USD | 14.44% |
| 2018 Q3 | 1.43 Million USD | 0.05% |
| 2017 FY | 1.43 Million USD | 7.5% |
| 2016 FY | 1.33 Million USD | 0.0% |
| 2015 FY | 1.33 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -29.391% |
| Ansell Limited | 1.32 Billion USD | 99.771% |
| Ansell Limited | 1.33 Billion USD | 99.772% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 97.593% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -222.367% |
| Psykey, Inc. | 2.47 Million USD | -22.896% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.849% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.85% |
| Encision Inc. | 1.98 Million USD | -53.252% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Innovative MedTech Inc. | 6.13 Million USD | 50.439% |
| LifePoint, Inc. | 2.45 Million USD | -23.89% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 70.136% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 10.574% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -0.005% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -291.648% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.69% |
| Sector 10, Inc. | 9.84 Million USD | 69.118% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.776% |
| SheerVision, Inc. | 1.43 Million USD | -112.413% |
| United Health Products, Inc. | 1.99 Million USD | -52.11% |
| Vasamed, Inc. | 1 Million USD | -202.445% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 19.993% |
| Yubo International Biotech Limited | 2.91 Million USD | -4.343% |